Angioni, DavideDelrieu, J.Hansson, O.Fillit, H.Aisen, P.Cummings, J.Sims, J. R.Braunstein, J. B.Sabbagh, M.Bittner, T.Pontecorvo, M.Bozeat, S.Dage, J. L.Largent, E.Mattke, S.Correa, O.Gutierrez Robledo, L. M.Baldivieso, V.Willis, D. R.Atri, A.Bateman, R. J.Ousset, P. J.Vellas, B.Weiner, M.EU/US/CTAD Task Force2023-06-272023-06-272022-10-12Angioni, D, Delrieu, J, Hansson, O, Fillit, H, Aisen, P, Cummings, J, Sims, J R, Braunstein, J B, Sabbagh, M, Bittner, T, Pontecorvo, M, Bozeat, S, Dage, J L, Largent, E, Mattke, S, Correa, O, Gutierrez Robledo, L M, Baldivieso, V, Willis, D R, Atri, A, Bateman, R J, Ousset, P J, Vellas, B, Weiner, M & EU/US/CTAD Task Force 2022, 'Blood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Force', Journal of Prevention of Alzheimer's Disease, vol. 9, no. 4, pp. 569-579. https://doi.org/10.14283/jpad.2022.852274-5807ORCID: /0000-0002-3722-4476/work/136883025https://hdl.handle.net/2164/21030Additional information Task force members: Sandrine Andrieu (Toulouse, France), Phyllis Barkman Ferrell (Indianapolis, USA), Russell Barton (Baltimore, USA), Monika Baudler (Basel, Switzerland), Navia Bradford (Cambridge, USA), Brady Burgess (San Francisco, USA), Brian Campbell (San Francisco, USA), Chris Dague (Malvern, USA), Francesca De Simone (Malvern, USA), Robert Dean (Indianiapolis, USA), Jean-Cosme Dodart (Dallas, USA), Rachelle Doody (Basel, Switzerland), Kristen Eisterhold (Indianapolis, USA), Stephane Epelbaum (Indianapolis, USA), Sven Eriksson (Stockholm, Sweden), Rianne Esquvel (Malvern, USA), Michela Gallagher (Baltimore, USA), Hideki Garren (San Francisco, USA), Sarah Giardina (New York, USA), Ishtar Govia (Kingston, Jamaica), Virginie Gregoire (Indianapolis, USA), Harald Hampel (Nutley, USA), Charles Harrington (Aberdeen, United Kingdom), James Hendrix (Indianapolis, USA), Dave Henley (Titusville, USA), Joseph Herring (North Wales, USA), Helen Hu (Nutley, USA), Farhad Imam (Kirkland, USA), Michael Irizarry (Nutley, USA), Peter Johannsen (Bagsvaerd, Denmark), Paul Kinnon (Solana Beach, USA), Hartmuth Kolb (Titusville, USA), Hisatomo Kowa (Kobe, Japan), Akihiko Koyama (Nutley, USA), Lynn Kramer (Nutley, USA), Lars Lannfelt (Uppsala, Sweden), John Lawson (Malvern, USA), Ferenc Martenyi (San Francisco, USA), Sarah McManus (Titusville, USA), David Miller (Blue Bell, USA), Sonya Miller (Aberdeen, United Kingdom), Richard Mohs (Baltimore, USA), Laura Nisenbaum (New York, USA), Gunilla Osswald (Stockholm, Sweden), Suzanne Ostrowitzki (San Francisco, USA), Lewis Penny (Aberdeen, United Kingdom), Elizabeth Pittampalli (San Francisco, USA), Craig Ritchie (Edinburgh, United Kingdom), Andrew Roche (Dublin, Ireland), Yves Rolland (Toulouse, France), Sharon Rosenzweig-Lipson (Baltimore, USA), Peter Schuler (Langen, Germany), Maria Eugenia Soto Martin (Toulouse), Reisa Sperling (Boston, USA), Erik Stoops (Gent, Belgium), Aishwarya Sukumar (Kirkland, USA), Charlotte Thim Hansen (Bagsvaerd, Denmark), Jacques Touchon (Montpellier, France), Martin Traber (Basel, Switzerland), Gallen Triana-Baltzer (Titusville, USA), Eugeen Vanmechelen (Gent, Belgium), Huijing Yu (Dallas, USA), Wagner Zago (San Francisco, USA), Nancy Zhang (Titusville, USA).114021542engSDG 3 - Good Health and Well-beingAlzheimer’s diseaseamyloidblood biomarkersclinical trialsdiagnosticneurofilament lightp-tauClinical NeurologyPsychiatry and Mental healthJournal article10.14283/jpad.2022.85http://www.scopus.com/inward/record.url?scp=85140235833&partnerID=8YFLogxK94